Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER)
Journal of Basic Microbiology · 2024
DOI: 10.1002/jobm.202300490 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Basic Microbiology, 2024. Verfasst von Fatemeh Saleh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. Hauptthemen laut MEDLINE: Zinc Oxide, Leishmania major, Antiprotozoal Agents, Meglumine Antimoniate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Currently, zinc oxide (ZnO) particles are used in nanotechnology to destroy a wide range of microorganisms. Although pentavalent antimony compounds are used as antileishmanial drugs, they are associated with several limitations and side effects. Therefore, it is always desirable to try to find new and effective treatments. The aim of this research is to determine the antileishmanial effect of ZnO particles in comparison to the Antimoan Meglumine compound on promastigotes and amastigotes of Leishmania major (MRHO/IR/75/ER). After the extraction and purification of macrophages from the peritoneal cavity of C57BL/6 mice, L. major parasites were cultured in Roswell Park Memorial Institute‐1640 culture medium containing fetal bovine serum (FBS) 10% and antibiotic. In this experimental study, the effect of different concentrations of nanoparticles was investigated using the 3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyl‐tetrazolium bromide (MTT) colorimetric method, in comparison to the glucantime on promastigotes, amastigotes and healthy macrophages in the culture medium. The amount of light absorption of the obtained color from the regeneration of tetrazolium salt to the product color of formazan by the parasite was measured by an enzyme‐linked immunosorbent assay (ELISA) reader, and the IC 50 value was calculated. IC 50 after 24 h of incubation was calculated as IC 50 = 358.6 µg/mL. The results showed, that the efficacy of ZnO nanoparticles was favorable and dose‐dependent. The concentration of 500 µg/mL of ZnO nanoparticles induced 84.67% apoptosis after 72. Also, the toxicity of nanoparticles was less than the drug. Nanoparticles exert their cytotoxic effects by inducing apoptosis. They can be suitable candidates in the pharmaceutical industry in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Medical Parasitology and Mycology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department of Animal Science, Lorestan Agricultural and Natural Resources Research and Education Center, Khorramabad, Iran.
ORCID-Profile: Fatemeh Saleh
Zitieren
APA
Saleh, F., Kheirandish, F., Abbasi, M., Ahmadpour, F., Veiskarami, S., & Mirderikvand, A. (2024). Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER). Journal of Basic Microbiology. https://doi.org/10.1002/jobm.202300490
Vancouver
Saleh F, Kheirandish F, Abbasi M, Ahmadpour F, Veiskarami S, Mirderikvand A. Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER). Journal of Basic Microbiology. 2024. doi:10.1002/jobm.202300490
BibTeX
@article{Saleh2024,
author = {Saleh, Fatemeh and Kheirandish, Farnaz and Abbasi, Mohammad and Ahmadpour, Fatemeh and Veiskarami, Saeed and Mirderikvand, Atefe},
title = {Comparison of biosynthetic zinc oxide nanoparticle and glucantime cytotoxic effects on Leishmania major (MRHO/IR/75/ER)},
journal = {Journal of Basic Microbiology},
year = {2024},
doi = {10.1002/jobm.202300490}
}
EUVIMED